戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              NER and normalization systems are also typically used in
2                                              NER crossing the midline was the only morphologic featur
3                                              NER protects against skin cancer.
4 me (XPC-1) and transcription-coupled (CSB-1) NER in ICL sensing were exposed.
5 o replicative stress significantly abrogates NER uniquely during S phase.
6                                     Accurate NER systems require task-specific, manually-annotated da
7 d on our results, we created the stand-alone NER tool HUNER incorporating fully trained models for fi
8         Together, these analyses identify an NER-related mutational signature and highlight the relat
9  In summary, in human cell extracts, BER and NER activities co-exist and excise Gh and Sp DNA lesions
10 uct ratios may depend on competitive BER and NER protein binding to these lesions.
11 ons are excellent substrates of both BER and NER.
12 e relationship between protein oxidation and NER inhibition was investigated in cultured human cells
13 y and another tie between the proteasome and NER regulators.
14 are positioned to reduce local stability and NER activity, whereas residues mutated in XP-G/CS have i
15 he XPB helicase subunit of transcription and NER factor TFIIH.
16 anscription efficiency was similar in WT and NER-deficient human cell lines, suggesting that the 5fC-
17 ure XPA-photodamage interactions, and assess NER function.
18 e mutations decreased activity in cell-based NER assays, demonstrating the functional importance of X
19 oyed high-performance machine learning-based NER tools for concept recognition and trained our concep
20 erage, the multi-task models produced better NER results than the single-task models trained on a sin
21 s to predict microbial turnover and biogenic NER have been developed, having limited use when metabol
22 e used to estimate the formation of biogenic NER.
23 onsidered as a potential risk while biogenic NER from incorporation of labeled carbon into microbial
24 tity recognition (NER), including biomedical NER.
25  and suggest how XPG complexes may bind both NER bubble junctions and replication forks.
26 DB is a general sensor of DNA damage in both NER and BER pathways, facilitating damage recognition in
27  transcription in human cells that lack both NER and TCR.
28 ) expedites the recognition of DNA damage by NER components via transcription-coupled DNA repair (TCR
29        DNA lesions are initially detected by NER factors XPC and XPE or stalled RNA polymerases, but
30 sincorporated ribonucleotides are removed by NER followed by error-prone resynthesis with DnaE.
31 bulky lesions are preferentially repaired by NER.
32 and that oxidative damage to RPA compromises NER capability.
33 elial cancer, a tumor type in which the core NER gene ERCC2 is significantly mutated.
34 nucleotide polymorphisms (rSNPs) of the core NER genes modulate clinical outcome of patients with adv
35 07) and chemicals (BioCreative 5 CDR corpus, NER f-score: 0.914, normalization f-score 0.895).
36 erformance on diseases (NCBI Disease corpus, NER f-score: 0.829, normalization f-score: 0.807) and ch
37 nomic NER (GG-NER) and transcription coupled NER (TC-NER) subpathways.
38                                    Defective NER is associated with photosensitivity and a high skin
39 nerate reactive oxygen species that diminish NER capacity by causing protein damage.
40  allowing UvrB to orchestrate the downstream NER reactions.
41 dinating damage incision by nucleases during NER, but the underlying mechanisms remain unclear.
42 ate in the damage recognition process during NER, allowing dynamic DNA damage detection at a distance
43 regulate the helicase activity of XPD during NER, p62 is thought to be purely structural.
44 We show that MMSET is required for efficient NER and that it catalyzes the dimethylation of histone H
45  involving XPC, TFIIH, and XPA for efficient NER.
46 vestigated associations of 25 rSNPs in eight NER genes with progression free survival (PFS) and overa
47  the two overlapping branches that encompass NER, transcription-coupled repair or global genome repai
48 damage, which is essential for cAMP-enhanced NER.
49    XPA is an essential protein in eukaryotic NER, although reports about its stoichiometry and role i
50  unwinding and damage incision in eukaryotic NER.
51 om The Cancer Genome Atlas dataset exhibited NER alterations, including nonsynonymous or splice site
52 classifier, with a rich feature approach for NER and supervised semantic indexing for normalization.
53 ds trainable for many entity types exist for NER, normalization methods are usually specialized to a
54        We show here that RPA is limiting for NER and that oxidative damage to RPA compromises NER cap
55           We present a single-task model for NER, a Multi-output multi-task model and a Dependent mul
56 [c]Ph-N(6)-dA, which is a poor substrate for NER but also blocks transcription in vitro, was tested.
57 data showing that it is a poor substrate for NER.
58 C-polypeptide lesion is a weak substrate for NER.
59 2, the major sensor initiating global genome NER (GG-NER), and that the interaction was enhanced upon
60 lls and cells defective in the global genome-NER (GG-NER) subpathway, we establish how this alters th
61 sion repair (NER) consists of global genomic NER (GG-NER) and transcription coupled NER (TC-NER) subp
62 e excision repair (TC-NER) or global genomic NER (GG-NER).
63 efficient XPC recruitment and global genomic NER.
64 in Core7 to promote NER, whereas non-genuine NER substrates have no such effect.
65 nuate GG-NER, do not substantially affect GG-NER or TC-NER.
66 e genomic locations, which we refer to as GG-NER complex binding sites (GCBSs).
67 t for T73F and T73Y that mildly attenuate GG-NER, do not substantially affect GG-NER or TC-NER.
68 ith histone H2B, significantly attenuates GG-NER and Rad26-independent TC-NER but does not affect TC-
69  chromatin remodeling is initiated during GG-NER.
70            ZRF1 is an essential factor in GG-NER, and its function at damaged chromatin sites is link
71 air (NER) consists of global genomic NER (GG-NER) and transcription coupled NER (TC-NER) subpathways.
72 cells defective in the global genome-NER (GG-NER) subpathway, we establish how this alters the distri
73 ajor sensor initiating global genome NER (GG-NER), and that the interaction was enhanced upon UV irra
74 on repair (TC-NER) or global genomic NER (GG-NER).
75                        The attenuation of GG-NER and Rad26-independent TC-NER by the H4H75E mutation
76 We also examined the genomic locations of GG-NER factor binding to chromatin before and after UV irra
77         We demonstrate that initiation of GG-NER in chromatin is accompanied by the disruption of dyn
78 facilitate the lesion recognition step of GG-NER via its interaction with DDB2 at the lesion site.
79  at the UV-induced DNA lesions to promote GG-NER.
80 subpathway of nucleotide excision repair (GG-NER) for removal of UV-induced direct photolesions from
81 global genome-nucleotide excision repair (GG-NER) in chromatin is organized into domains in relation
82 global genome nucleotide excision repair (GG-NER) pathway.
83  and after UV irradiation, revealing that GG-NER is organized and initiated from specific genomic loc
84      In undamaged cells, we show that the GG-NER complex occupies chromatin, establishing the nucleos
85 tyl-transferase Gcn5 is controlled by the GG-NER complex, which regulates histone H3 acetylation and
86 namic nucleosomes that flank GCBSs by the GG-NER complex.
87 dent on the ubiquitination of Rad4 by the GG-NER E3 ligase, promotes UV survival in yeast cells.
88           Chromatin remodeling during the GG-NER process is therefore organized into these genomic do
89  the adduct but not as effectively as global NER.
90                 The interplay between global NER and TCR in repairing the polycyclic aromatic hydroca
91                           Hence, both global NER and TCR enhance the recovery of gene expression foll
92 ipt production in cells proficient in global NER but lacking TCR, indicating that TCR is necessary fo
93 at measuring the combined status of MMR, HR, NER, and MGMT provided a more robust prediction of temoz
94                               The identified NER-DDXs were categorized into three groups according to
95 rms of RPA that are associated with impaired NER.
96 ecruitment of XPA to UV-damaged DNA, impairs NER and increases UV-induced mutagenesis.
97  be possible to use them together to improve NER performance.
98  nucleosomes shows the opposite asymmetry in NER-proficient skin cancers, but not in NER-deficient ca
99 irs growth in cells genetically deficient in NER, but did not show any sensitivity to the repair gene
100  and energetic origins of this difference in NER-incision efficiencies.
101 ve may be a common way to interrogate DNA in NER.
102 tion, the role of UvrA's 2 ATPase domains in NER remains elusive.
103 omplementary views of the k-mers involved in NER and NDR.
104 s, indicating that TFIIE was not involved in NER.
105 y in NER-proficient skin cancers, but not in NER-deficient cancers, indicating that asymmetric repair
106 fect on transcription in cells proficient in NER but lacking TCR, indicating that NER can remove the
107        To elucidate substrate specificity in NER, we have prepared homogeneous human ten-subunit TFII
108 and the DNA-binding activity of human XPA in NER, we used NMR to investigate the interaction of its D
109  In Escherichia coli, UvrA and UvrB initiate NER, although the mechanistic details of how this occurs
110 chanism of telomeric photoproduct removal is NER.
111 e the first machine learning model for joint NER and normalization during both training and predictio
112  of our model as a general toolkit for joint NER and normalization.
113 hich promoted ATR's interaction with the key NER factor xeroderma pigmentosum A (XPA) and facilitated
114 ) at Ser435, which actively recruits the key NER protein xeroderma pigmentosum complementation group
115               In primary human cells lacking NER, (+)-trans-anti-B[a]P-N(6)-dA exhibited a deleteriou
116  sensitive and quantitative assay to measure NER activity in human cells, which we term the Oligonucl
117  UVRAG as a regulator of CRL4(DDB2)-mediated NER and suggest that its expression levels may influence
118 with UV-damaged DNA and optimize melanocytic NER.
119 nhibitor, 26 PPIs in DDR pathways (BER, MMR, NER, NHEJ, HR, TLS, and ICL repair) are specifically dis
120 aled how XPA DBD and RPA70AB orient on model NER DNA substrates.
121            We conclude that jointly modeling NER and normalization greatly improves performance.
122                         Importantly, neither NER alteration affected HR or conferred sensitivity to P
123                              However, normal NER activity appeared when the XPC(-/-) cell extracts we
124 ll known to profoundly inhibit the access of NER proteins.
125  recognition in the global-genomic branch of NER.
126  recognition in the global-genomic branch of NER.
127  metabolism and is an essential component of NER.
128 e site mutations and homozygous deletions of NER genes.
129 stablish how this alters the distribution of NER rates throughout the genome.
130 ificantly alters the genomic distribution of NER rates; this has implications for the effects of chro
131 s are characterized by lower efficiencies of NER and DSB/R mechanisms, resulting in higher accumulati
132                                 Evolution of NER, unlike DSB, is shaped primarily by sunlight exposur
133  of the LRS domain, or lowered expression of NER proteins.
134 n, and thermochemolysis to study the fate of NER-DDX along different environmental aquatic-terrestria
135 d results, a conceptual model of the fate of NER-DDXs on their different environmental aquatic-terres
136  midline was the only morphologic feature of NER associated with poor survival (log-rank test, P = .0
137 cally characterized by genetic impairment of NER, such as skin and testicular cancers.
138  are characterized by profound inhibition of NER exclusively during S phase.
139 his mechanism, pharmacological inhibition of NER using spironolactone abolished SIRT2-mediated TC-NER
140     Responders' BMPCs showed slower rates of NER and DSB/R (P <0022), similar rates of ICL/R, and mor
141 larly, RPMI8226 cells showed slower rates of NER and DSB/R, comparable rates of ICL/R, more condensed
142 r results strongly suggest that reduction of NER capacity during periods of enhanced replicative stre
143 ural hearing loss is observed in a subset of NER-associated DNA repair disorders including Cockayne s
144  mechanism that integrates ubiquitination of NER DNA repair factors with the regulation of the transc
145                         The vulnerability of NER to inhibition by oxidation provides a connection bet
146 s ablated the stimulatory effect of SIRT6 on NER and destabilized the genome due to (i) partial loss
147 or manifestation of this defect, and S phase NER proficiency is correlated with the capacity of indiv
148 ly reduce transcription efficiency, are poor NER substrates, and do not cause transcription errors.
149 f UvrA, the initiating enzyme of prokaryotic NER, to an alkyl lesion by ATL.
150 ties of both XPB and XPD in Core7 to promote NER, whereas non-genuine NER substrates have no such eff
151  Overall, we demonstrate that SIRT6 promotes NER by deacetylating DDB2, thereby preventing the onset
152 2-independent function for EZH2 in promoting NER through DDB2 stabilization, suggesting a rationale f
153 nes, activating an Mfd-dependent error-prone NER mechanism.
154 enon, we developed a novel assay to quantify NER kinetics as a function of cell cycle in the model or
155 depend on accurate named entity recognition (NER) and normalization (grounding).
156                    Named Entity Recognition (NER) is a key task in biomedical text mining.
157 corpora suggesting named-entity recognition (NER) to be more challenging than anticipated: 28-77% of
158 oncept embeddings, named-entity recognition (NER) tools are first used to identify and normalize conc
159 tate-of-the-art in named entity recognition (NER), including biomedical NER.
160 osome enriched and depleted genomic regions (NER and NDR for short) that is: (i) exhaustive and withi
161 ered an important role of USP7 in regulating NER via deubiquitinating XPC and by preventing its VCP/p
162 Sp DNA lesions, suggesting that the relative NER/BER product ratios may depend on competitive BER and
163    In PBT and vPvB assessment, remobilisable NER are considered as a potential risk while biogenic NE
164              Nucleotide excision DNA repair (NER) pathway mutations cause neurodegenerative and proge
165 or efficient nucleotide excision DNA repair (NER).
166  proteins of the nucleotide excision repair (NER) and base excision repair (BER) pathways work in a c
167  DDB2 to promote nucleotide excision repair (NER) and govern cisplatin resistance in SCLC.
168 thways including nucleotide excision repair (NER) and inter-strand crosslink repair (ICLR).
169           Global nucleotide excision repair (NER) and transcription-coupled DNA repair (TCR) are amon
170 Given the use of nucleotide excision repair (NER) as a backup pathway for RER in RNase HII-deficient
171 on that enhances nucleotide excision repair (NER) by facilitating recruitment of the XPA protein to s
172     Mutations in nucleotide excision repair (NER) components (e.g. XPA-1 and XPF-1) imparted extreme
173                  Nucleotide excision repair (NER) consists of global genomic NER (GG-NER) and transcr
174 ttributed to the nucleotide excision repair (NER) defect as well as to impaired transcription.
175 d by a dedicated Nucleotide Excision Repair (NER) enzyme.
176  motifs found in nucleotide excision repair (NER) factors and transcription factors known to interact
177                  Nucleotide excision repair (NER) in eukaryotes is orchestrated by the core form of t
178                  Nucleotide excision repair (NER) is a conserved and versatile DNA repair pathway for
179                  Nucleotide excision repair (NER) is a highly conserved pathway that removes helix-di
180                  Nucleotide excision repair (NER) is a major DNA repair pathway for a variety of DNA
181                  Nucleotide excision repair (NER) is an evolutionarily conserved mechanism that proce
182                  Nucleotide excision repair (NER) is responsible for the removal of a large variety o
183                  Nucleotide excision repair (NER) is the key DNA repair system that eliminates the ma
184 the multiprotein nucleotide excision repair (NER) machinery.
185 in multi-protein nucleotide excision repair (NER) machinery.
186 leosomes inhibit nucleotide excision repair (NER) of the nontranscribed strand (NTS) of genes in an a
187 erations in the nucleotide- excision repair (NER) pathway has not yet been identified.
188 air pathway, the nucleotide excision repair (NER) pathway, which may exhibit a discordance in sensiti
189 mutations in the nucleotide excision repair (NER) pathway, which repairs DNA damage from UV exposure.
190 to repair by the nucleotide excision repair (NER) pathway.
191 ticipates in the nucleotide excision repair (NER) pathway.
192  function in the nucleotide excision repair (NER) pathway.
193 in the bacterial nucleotide excision repair (NER) pathway.
194 repaired via the nucleotide excision repair (NER) pathway.
195                  Nucleotide excision repair (NER) plays a vital role in platinum-induced DNA damage d
196                  Nucleotide excision repair (NER) protects against sunlight-induced skin cancer.
197                  Nucleotide excision repair (NER) protects cells against diverse types of DNA damage,
198                  Nucleotide excision repair (NER) proteins have been found to play a prominent role i
199 We find that the nucleotide excision repair (NER) proteins UvrA, UvrB, and UvrC, but not RecA, are re
200  distribution of nucleotide excision repair (NER) rates for UV-induced lesions throughout the budding
201  SIRT6 regulates nucleotide excision repair (NER) remains unknown.
202                  Nucleotide excision repair (NER) removes a wide range of DNA lesions, including UV-i
203                  Nucleotide excision repair (NER) removes chemically diverse DNA lesions in all domai
204                  Nucleotide excision repair (NER) removes these photoproducts, but whether NER functi
205                  Nucleotide excision repair (NER) removes various DNA lesions caused by UV light and
206 nformation about nucleotide excision repair (NER) stimulated by cAMP-dependent signaling downstream o
207 eins involved in nucleotide excision repair (NER) under normal growth conditions.
208 ch repair (MMR), nucleotide excision repair (NER), and homologous recombination (HR) capacity contrib
209  in human global nucleotide excision repair (NER), binds avidly to abasic sites and 8-oxo-guanine (8-
210  repair, but not nucleotide excision repair (NER), coevolves with longevity.
211                  Nucleotide excision repair (NER), interstrand cross-links repair (ICL/R), double-str
212 on repair (BER), nucleotide excision repair (NER), mismatch repair (MMR), non-homologous end joining
213  the activity of nucleotide excision repair (NER), the most versatile DNA repair process.
214 a characteristic nucleotide excision repair (NER)-induced ladder of short dual incision oligonucleoti
215  photolesions by nucleotide excision repair (NER).
216 e to UV light is nucleotide excision repair (NER).
217  endonuclease in nucleotide excision repair (NER).
218 are deficient in nucleotide excision repair (NER).
219 or cAMP-enhanced nucleotide excision repair (NER).
220 rily repaired by nucleotide excision repair (NER).
221 ranscription and nucleotide excision repair (NER).
222 of global-genome nucleotide excision repair (NER).
223                     Nonextractable residues (NER) are pollutants incorporated into the matrix of natu
224 of the formation of nonextractable residues (NER).
225 n, and formation of nonextractable residues (NER).
226 ide a biophysical explanation for the severe NER deficiencies caused by this mutation.
227 um complementation group F), leads to severe NER pathway deficiencies.
228 n the single-task models trained on a single NER dataset.
229                                    Among six NER factors found to be regulated by the proteasome, we
230 fa1 recapitulates defective S phase-specific NER in wild type yeast; moreover, ectopic RPA1-3 overexp
231  embeddings generally suffer from suboptimal NER tools, small-scale evaluation, and limited availabil
232 hich is of central importance for successful NER, has remained enigmatic.
233 ns to the nucleotide excision repair system (NER).
234                                           TC-NER deficiency in humans is associated with the severe n
235 26-independent TC-NER but does not affect TC-NER in the presence of Rad26.
236 he 5'-3' direction with slow recovery and TC-NER at the 3' end of long genes.
237 mplicated in transcriptional stalling and TC-NER in the cell remain unknown.
238 tes error-free transcriptional bypass and TC-NER of UV photoproducts.
239 a key transcription elongation factor and TC-NER repressor, from the chromatin.
240 olog CSB have been proposed to facilitate TC-NER in part by positioning and stabilizing stalling of R
241 ypass of DNA lesions by Rad26 facilitates TC-NER.
242 6 and its ATPase activity is critical for TC-NER downstream of the first (+1) nucleosome in gene codi
243  oxidative DNA damage, but proficient for TC-NER.
244 scription stalling might be important for TC-NER.
245                              Furthermore, TC-NER interacts with mismatch repair (MMR) under physiolog
246                                  However, TC-NER on the transcription start site (TSS)-proximal half
247 nstrate that the requirement for Rad26 in TC-NER is modulated by the distribution of TFIIH and Spt4/S
248 ide misincorporation is not implicated in TC-NER, and moderate eviction of Spt5 and promotion of erro
249 ver, the genome-wide role of CSB/Rad26 in TC-NER, particularly in the context of the chromatin organi
250 y attenuates GG-NER and Rad26-independent TC-NER but does not affect TC-NER in the presence of Rad26.
251 tenuation of GG-NER and Rad26-independent TC-NER by the H4H75E mutation is not due to decreased chrom
252 g spironolactone abolished SIRT2-mediated TC-NER activity in differentiated neuronal cells and protec
253 R (GG-NER) and transcription coupled NER (TC-NER) subpathways.
254                             Initiation of TC-NER is mediated by specific factors such as the human Co
255 ER, do not substantially affect GG-NER or TC-NER.
256 ry 1: XP-A, B, D, F, and G) and preserved TC-NER (category 2: XP-C, E, and V).
257 downstream of the +1 nucleosome to remove TC-NER suppression by Spt4/Spt5.
258 ption coupled nucleotide excision repair (TC-NER) (category 1: XP-A, B, D, F, and G) and preserved TC
259 ption-coupled nucleotide excision repair (TC-NER) factor Cockayne syndrome group B (CSB), but not the
260             Transcription coupled repair (TC-NER) is a subpathway of nucleotide excision repair trigg
261 ption-coupled nucleotide excision repair (TC-NER) is an important DNA repair mechanism that removes R
262 ption-coupled nucleotide excision repair (TC-NER) of cisplatin-induced DNA cross-links.
263 ption-coupled nucleotide excision repair (TC-NER) or global genomic NER (GG-NER).
264 ption-coupled nucleotide excision repair (TC-NER), contains a ubiquitin-binding domain (UBD), but the
265 ption-coupled nucleotide excision repair (TC-NER).
266 t deletion of SPT4 significantly restores TC-NER across the genome in a rad26Delta mutant, particular
267 on elongation factor Spt4/Spt5 suppresses TC-NER in Rad26-deficient cells.
268 sponse to chromosomal triplex formation than NER-proficient cells.
269 tected from ultraviolet irradiation and that NER preserves telomere integrity.
270 rom UV-irradiated human cells indicates that NER activity along the NTS is also elevated on the 5' si
271 ient in NER but lacking TCR, indicating that NER can remove the lesion in the absence of TCR, which i
272                                 We show that NER initiation involves a two-step mechanism in which Uv
273 as BRCA1/2-mutated patients, suggesting that NER pathway inactivation in EOC conferred enhanced plati
274 ional impairments that are distinct from the NER disorder XP.
275 eview focuses on recent data showing how the NER proteins, XPA, XPC, XPG, CSA, CSB and UV-DDB, work t
276          We find that cells deficient in the NER damage recognition proteins, XPA and XPC, accumulate
277 r results identified SIRT2's function in the NER pathway as a key underlying mechanism of preventing
278                                Moreover, the NER factor XPA activates unwinding of normal DNA by Core
279 age sites facilitates the recruitment of the NER factor XPA.
280 f the structure and mechanical action of the NER machinery.
281 scription-coupled repair (TCR) branch of the NER pathway and exhibits developmental and neurological
282 the global genome repair (GGR) branch of the NER pathway and have a very high incidence of UV-induced
283        Although the general mechanism of the NER process is well studied, the function of the XPA pro
284 ading errors and limiting the ability of the NER system to directly exploit the lexical information p
285  to FICZ/UVA-induced oxidation damage to the NER proteome and DNA excision repair is impaired in extr
286 cer by promoting photochemical damage to the NER proteome and thereby preventing the removal of UVB-i
287 troversy about where XPA is bound within the NER bubble, provide structural insights into the molecul
288 substrates of XPA as it functions within the NER machinery.
289 sions are probably directly repaired through NER.
290 in removing DNA damage that is refractory to NER.
291 rans-anti-B[a]P-N(6)-dA, which is subject to NER and blocks transcription in vitro, and (+)-trans-ant
292                                Moreover, two NER mutations (ERCC6-Q524* and ERCC4-A583T), identified
293       This finding was confirmed by in vitro NER assays in cell-free extracts from human HeLa cells,
294           The ladders were not observed when NER was inhibited either by mouse monoclonal antibody (5
295 ER) removes these photoproducts, but whether NER functions at telomeres is unresolved.
296  of radiolabeled nucleosides associated with NER.
297 ICLs (TFO-ICLs) in vitro, cooperatively with NER damage recognition proteins, promoted removal of UVC
298       Furthermore, patients with tumors with NER alterations had similar OS and PFS as BRCA1/2-mutate
299                                  Tumors with NER alterations were associated with improved overall su
300 rvival (PFS), compared with patients without NER alterations or BRCA1/2 mutations.

 
Page Top